BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » MSCs » Page 55

Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).

Breakdown of Mesenchymal Stem Cell Clinical Trials, by Phase, Geography, Sponsors, and More

By 2 Comments

Historical Number of Mesenchymal Stem Cell Clinical Trials (IFCB)

In 2014, the International Federation for Cell Biology (IFCB) conducted an analysis of mesenchymal stem cell clinical trials, identifying that 313 clinical trials involved mesenchymal stem cells (MSCs). The majority of these clinical trials (41.7%) were in Phase I/II. Another  23.7% of these studies were in Phase II. However, only 4.2% of these clinical trials had progressed to Phase III. As such, it is clear that the bulk of MSC clinical trials remain in the early stages of development.

Among the clinical trials that progressed through Phase III, one of the most promising stem cell therapies to emerge was Prochymal, an allogenic mesenchymal stem cell therapy derived from the bone marrow of adult donors and made by Osiris Therapeutics. Prochymal is produced by purifying MSCs from the bone marrow of donors, then culturing and packaging the cells, allowing up to 10,000 doses to be derived from a single donor.  [Read more…]

CarePilot and “Cord for Life” Find Innovative Way to Make Cord Blood Banking Affordable

By Leave a Comment

In August 2014, CarePilot USA, based in Newport Beach, California, announced a collaboration with the “Cord for Life” storage program offered by Lifeforce Cryobanks, a company based in Altamonte Springs, Florida.  Through this partnership, CarePilot is now offering significant discounts on the collection, processing, and storage of newborn umbilical cord blood.  Specifically, CarePilot is offering two, six, and 21-year storage plans at major discounts relative to the market rates offered by the “Cord for Life” program. [Read more…]

Top 5 Stem Cell Influencers on Twitter

By Leave a Comment

Do You Know the Top 5 Stem Cell Influencers on Twitter?

Twitter is one of the most widely used social media platforms that exists. There are now 316 million monthly active users and 500 million Tweets sent per day, according to Twitter’s company statistics.  In fact, every single minute of the day, there are nearly 350,000 Tweets posted to Twitter. Importantly, it is now one of the 9th most most visited website in the world, according to Alexa, an Amazon company that ranks relative traffic for websites. Within the United States, Twitter is the 8th most visited website, an absolutely incredible feat.  [Read more…]

Epic Year for Regenerative Medicine Investments

By Leave a Comment

In the past twelve months, regenerative medicine investments gained momentum, as new and promising clinical data got released. The momentum has been growing in recent years, enabling the cell therapy and genome editing sectors to evolve into a global industry.

[Read more…]

Mesenchymal Stem Cell Industry News Round Up | July 2015

By Leave a Comment

The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for July 2015.

[Read more…]

BioInformant's World-Class Clients